TrialPhase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
Trial details
- Registry ID
- NCT07010159
- Phase
- Phase 2, Phase 3
Drug research
KPL-387
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387NCT07010159 | KNSA | Phase 2, Phase 3 | Recruiting | 2027-12-31Estimated |
| Transition to KPL-387 Monotherapy Dosing & Administration StudyNCT07288216 | KNSA | Phase 2 | Recruiting | 2027-12-31Estimated |
Transition to KPL-387 Monotherapy Dosing & Administration Study
Trial details
- Registry ID
- NCT07288216
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |